BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 28774268)

  • 21. BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status.
    Pimenta J; Paulo C; Mascarenhas J; Gomes A; Azevedo A; Rocha-Gonçalves F; Bettencourt P
    Int J Cardiol; 2010 Nov; 145(2):209-214. PubMed ID: 19729213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
    York MK; Gupta DK; Reynolds CF; Farber-Eger E; Wells QS; Bachmann KN; Xu M; Harrell FE; Wang TJ
    J Am Coll Cardiol; 2018 May; 71(19):2079-2088. PubMed ID: 29747827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
    Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
    El-Saed A; Voigt A; Shalaby A
    Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
    Li X; Chen C; Gan F; Wang Y; Ding L; Hua W
    BMC Cardiovasc Disord; 2014 May; 14():67. PubMed ID: 24885051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of B-type natriuretic peptide levels on admission in patients with acute ST elevation myocardial infarction.
    Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Rudzki D; Główczyńska R; Rudowski R; Opolski G
    Acta Cardiol; 2005 Oct; 60(5):537-42. PubMed ID: 16261786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
    Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
    Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Six-Month Mortality in BNP-Matched Acute Heart Failure Patients.
    Lourenço P; Ribeiro A; Pintalhão M; Silva S; Bettencourt P
    Am J Cardiol; 2015 Sep; 116(5):744-8. PubMed ID: 26115901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of B-Type Natriuretic Peptide Level on Long-Term Outcome in Patients With End-Stage Heart Failure.
    Huang B; Shen J; Li L; Huang Y; Luo S
    Am J Cardiol; 2016 Aug; 118(3):383-8. PubMed ID: 27269584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
    Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
    Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.
    Santarelli S; Russo V; Lalle I; De Berardinis B; Navarin S; Magrini L; Piccoli A; Codognotto M; Castello LM; Avanzi GC; Villacorta H; Precht BLC; de Araújo Porto PB; Villacorta AS; Di Somma S;
    Intern Emerg Med; 2017 Jun; 12(4):445-451. PubMed ID: 27987064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
    Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
    Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
    Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of BNP Reduction During Hospitalization in Patients With Acute Heart Failure.
    Kagiyama N; Kitai T; Hayashida A; Yamaguchi T; Okumura T; Kida K; Mizuno A; Oishi S; Inuzuka Y; Akiyama E; Suzuki S; Yamamoto M; Shimizu A; Urakami Y; Toki M; Aritaka S; Matsumoto K; Nagano N; Yamamoto K; Matsue Y
    J Card Fail; 2019 Sep; 25(9):712-721. PubMed ID: 30965102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
    Bettencourt P; Ferreira-Coimbra J; Rodrigues P; Marques P; Moreira H; Pinto MJ; Guimarães JT; Lourenço P
    ESC Heart Fail; 2018 Dec; 5(6):1017-1022. PubMed ID: 30144302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry.
    Kociol RD; Greiner MA; Hammill BG; Eapen ZJ; Fonarow GC; Klaskala W; Mills RM; Curtis LH; Hernandez AF
    Am Heart J; 2012 Jun; 163(6):994-1001. PubMed ID: 22709752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.